Prognostic clinicopathological and FAP-1 and α-SMA as predictors of disease-specific survival in resected non-small-cell lung cancer patients and in subgroups with squamous cell carcinoma and adenocarcinoma (univariate analyses, log-rank test, n = 535, 289 and 201 respectively). The gene discussed is ACTA1; the disease is non-small cell lung carcinoma.